Epsilogen and Lonza have successfully completed the manufacturing of a potential cancer treatment. The complex process, which took less than ten months, was carried out...

Merck has expanded its Biologics Testing Center in China with 1,500 m2 of new biosafety laboratories. The company is investing a total of €29 million in its testing...

Samsung Biologics, a global contract development and manufacturing organization (CDMO), and Kurma Partners, a European venture capital firm in healthcare and...

The pharmaceutical market is undergoing a profound transformation, driven by innovation among biologics and advanced therapies (ATs). This shift is not only redefining...

The biopharmaceutical industry is experiencing a drive towards biologic products due to their promise as treatments for chronic diseases.

In response to the urgent need for sustainable solutions in the ­surfactants industry, companies like Locus Ingredients are developing environmentally friendly...

The Fill & Finish of biologic drugs is expensive and poses special technological challenges for CDMOs. At the German site in Hameln, Siegfried has successfully proven...

Science and technology group 3M has announced plans to invest $146 million to expand its biopharma filtration capabilities at manufacturing facilities in Europe. The...